Icon

ORLADEYO (nda214094)- (EQ 110MG BASE,EQ 150MG BASE)

BEROTRALSTAT HYDROCHLORIDE BIOCRYST
EQ 110MG BASE,EQ 150MG BASE
No No
2039-Nov-01 2025-Dec-03
None None
None No
ORLADEYO is a plasma kallikrein inhibitor indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years and older.
0 0 0
Total Other Developers 1
Drugs with Suitability No
EQ 110MG BASE ** ** - - -
EQ 150MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.